| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 02/04/1997 | US5599559 Calcium channel blocking polypeptide from agelenopsis aperta and therapeutic methods employing it |
| 02/04/1997 | US5599535 Administering a non-steroidal antiinflammatory agent preventing cell lose in eye disorders |
| 02/04/1997 | CA1338895C Diphosphonic acid derivatives, processes for the preparation thereof and pharmaceutical composition containing them |
| 02/03/1997 | CA2182469A1 Endothelin-receptor-antagonists |
| 01/30/1997 | WO1997003094A1 Cell adhesion inhibitors |
| 01/30/1997 | WO1997003086A1 Early onset alzheimer's disease gene and gene products |
| 01/30/1997 | WO1997003084A1 New inhibitors of platelet aggregation |
| 01/30/1997 | WO1997003076A1 Heterocycle-fused thiazole derivatives |
| 01/30/1997 | WO1997003069A1 Heterocyclic compounds and pharmaceutical compositions containing them |
| 01/30/1997 | WO1997003068A1 A triazolylmethyl-indole ethylamine bisulfate salt |
| 01/30/1997 | WO1997003066A1 Substituted benzolactam compounds as substance p antagonists |
| 01/30/1997 | WO1997003054A1 BENZO[g]QUINOLINE DERIVATIVES |
| 01/30/1997 | WO1997003050A1 4,9-ethano-benzo(f)isoindole derivatives as farnesyl transferase inhibitors |
| 01/30/1997 | WO1997003047A1 Novel farnesyl transferase inhibitors, preparation thereof and pharmaceutical compositions containing said inhibitors |
| 01/30/1997 | WO1997002840A1 Immunovectors for the intracellular and intranuclear transport |
| 01/30/1997 | WO1997002834A1 Analogs of parathyroid hormone |
| 01/30/1997 | WO1997002832A1 Lyophilized hgf preparations |
| 01/30/1997 | WO1997002830A2 Use of indigestible oligosaccharides to treat and prevent otitis media in humans |
| 01/30/1997 | WO1997002817A1 Compounds useful in the treatment of neurofibromatosis |
| 01/30/1997 | WO1997002813A1 Non-allosteric gabaa agonists for treating sleep disorders |
| 01/30/1997 | WO1996040745A3 Amino acid amides of 5-amino-1,3,4-thiadiazones and their use as inhibitors for matrix metalloproteinases |
| 01/30/1997 | DE19529025A1 Neue 8-bromsubstituierte cyclische Nucleotidester, Verfahren zu ihrer Herstellung und ihre Verwendung New 8-bromo-substituted cyclic Nucleotidester, processes for their preparation and their use |
| 01/30/1997 | CA2226868A1 Cell adhesion inhibitors |
| 01/30/1997 | CA2226758A1 New inhibitors of platelet aggregation |
| 01/30/1997 | CA2226658A1 Early onset alzheimer's disease gene and gene products |
| 01/30/1997 | CA2226623A1 Compounds useful in the treatment of neurofibromatosis |
| 01/30/1997 | CA2226420A1 Use of indigestible oligosaccharides to treat and prevent otitis media in humans |
| 01/30/1997 | CA2224436A1 Benzo [g] quinoline derivatives |
| 01/30/1997 | CA2224414A1 4,9-ethano-benzo(f)isoindole derivatives as farnesyl transferase inhibitors |
| 01/30/1997 | CA2224411A1 Novel farnesyl transferase inhibitors, preparation thereof and pharmaceutical compositions containing said inhibitors |
| 01/29/1997 | EP0756005A1 Gene coding for adseverins |
| 01/29/1997 | EP0755934A1 Endothelin receptor antagonists |
| 01/29/1997 | EP0755932A1 (Thiophen-2-yl)piperidin or tetrahydropyridin-azabicyclocarboxamides |
| 01/29/1997 | EP0755931A1 Dihydropyridine and pyridine derivatives and process for their preparation |
| 01/29/1997 | EP0755925A1 N,N'-di(aralkyl)-N,N'-di(2-azaaralkyl)alkylene-diamine derivatives and their use in pharmaceutical and cosmetic compositions |
| 01/29/1997 | EP0755917A1 N,N'-di(aralkyl) N,N'-di(carboxyalkyl) alkylen- di- or triamino-derivatives and N-(aralkyl) N'-(carboxyalkyl) N,N'-di (carboxyalkyl) alkylen- di- or triamino-derivatives and their use in pharmacy and cosmetics |
| 01/29/1997 | EP0755675A1 Dermatological and/or pharmaceutical composition, process of preparation and utilization |
| 01/29/1997 | EP0755408A1 Peptides for reducing or inhibiting bone resorption, angiogenesis and restenosis |
| 01/29/1997 | EP0755394A1 A method of inducing cholecystokinin agonist activity using 1,4-benzodiazepine compounds |
| 01/29/1997 | EP0755392A1 Alpha1c adrenergic receptor antagonists |
| 01/29/1997 | EP0755383A1 Inhibitors of farnesyl-protein transferase |
| 01/29/1997 | EP0755381A1 Substituted pyridine leukotriene b 4 antagonists |
| 01/29/1997 | EP0755372A1 Inhibitors of influenza virus neuraminidase and methods of making and using the same |
| 01/29/1997 | EP0755263A1 Compositions and methods for stimulating megakaryocyte growth and differentiation |
| 01/29/1997 | EP0755259A1 CHIMERIC INFECTIOUS BURSAL DISEASE VIRUS cDNA CLONES, EXPRESSION PRODUCTS AND VACCINES BASED THEREON |
| 01/29/1997 | EP0755249A1 Use of maillard reaction inhibitors for the treatment of amyloidosis-based disease |
| 01/29/1997 | EP0698012B1 Use of deoxygalactonojirimycin derivatives for inhibiting glycolipid synthesis |
| 01/29/1997 | EP0675878B1 Novel vitamin d analogues |
| 01/29/1997 | EP0655922B1 Antiproliferative oligomers |
| 01/29/1997 | EP0652755B1 Therapeutic use of phosphoryl-l-serine-n-acyl-sphingosine |
| 01/29/1997 | EP0633878B1 Novel vitamin d analogues |
| 01/29/1997 | EP0493446B1 Treatment of autoimmune disease |
| 01/29/1997 | CN1141637A Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| 01/29/1997 | CN1141625A Vitamin D amine and amine derivatives |
| 01/29/1997 | CN1141590A Agent for prophylaxis and treatment of thromboxane A2-mediated diseases |
| 01/29/1997 | CN1141589A Film coated tablet of paracetamol and domperidone |
| 01/29/1997 | CN1141297A Pyrazolopyrimidines and pyrrolopyrimidines for treatment of neuronal and other disorders |
| 01/29/1997 | CN1141291A 4-(Arylaminomethylene)-2,4-dihydro-3-pyrazolones |
| 01/29/1997 | CA2182226A1 Dermatological or pharmaceutical composition; process for preparing and uses |
| 01/29/1997 | CA2182156A1 Endothelin-receptor-antagonists |
| 01/28/1997 | US5597915 Antagonists of cholecystokinin and gastrin receptors |
| 01/28/1997 | US5597898 NF-κB activation regulatory protein, IκB-β |
| 01/28/1997 | US5597897 Polymer matrix made from lactic acid and/or glycolic acid for sequestering proteins |
| 01/28/1997 | US5597845 Tachykinin antagonists |
| 01/28/1997 | US5597833 Leukotriene synthesis inhibitors for antiinflammatory agents, respiratory system disorders, antiallergens or antiischemic agents |
| 01/28/1997 | US5597830 Antitumor agents for prostate or breast cancer |
| 01/28/1997 | US5597826 Compositions containing sertraline and a 5-HT1D receptor agonist or antagonist |
| 01/28/1997 | US5597823 Treating benign prostatic hyperplasia |
| 01/28/1997 | US5597808 Use of pseudopterosins for promoting wound healing |
| 01/28/1997 | US5597803 Bradykinin peptides with modifications at the N terminus |
| 01/28/1997 | US5597797 Administering growth hormone and insulin-like growth factor |
| 01/28/1997 | US5597710 Genetic engineering |
| 01/28/1997 | US5597709 Human growth hormone splice variants hGHV-2(88) and hGHV-3(53) |
| 01/28/1997 | US5597558 Use of extracts of filamentous bacteria as cosmetic agents to combat ageing of the skin |
| 01/28/1997 | CA2039194C Uses of l-deprenyl and compositions for same |
| 01/27/1997 | CA2182113A1 N,n'-di(aralkyl) n,n'-di(2-azaaralkyl) alkylene diamine derivatives and their use in pharmaceutical and cosmetic compositions |
| 01/27/1997 | CA2182112A1 N,n'-di(aralkyl) n,n'-di(carboxyalkyl) alkylene di- or triamine and n-(aralkyl) n'-(carboxyalkyl) n,n'-di(carboxyalkyl) alkylene di- or triamine derivatives and their use in pharmaceutical or cosmetic applications |
| 01/27/1997 | CA2181759A1 (thiophen-2-yl)-piperidin or tetrahydropyridin azabicyclocarboxamides |
| 01/23/1997 | WO1997002289A1 Peptide inhibitors of fibronectine |
| 01/23/1997 | WO1997002269A1 Condensed thiazole derivatives, having 5-ht receptor affinity |
| 01/23/1997 | WO1997002268A1 7,7-disubstituted cephem-4-ketones |
| 01/23/1997 | WO1997002266A1 Pyrrolopyrimidines and processes for the preparation thereof |
| 01/23/1997 | WO1997002254A1 Quinazoline derivatives |
| 01/23/1997 | WO1997002249A1 Novel azepanes and their ring homologues for therapy and prophylaxis of protein kinase mediated diseases |
| 01/23/1997 | WO1997002244A1 Heterocyclic carboxylic acid derivatives and drugs containing the same |
| 01/23/1997 | WO1997002052A1 Method for detecting or monitoring the effectiveness of treatment of t cell mediated diseases |
| 01/23/1997 | WO1997002051A2 Cascade polymer complexes |
| 01/23/1997 | WO1997002049A1 Neuronal progenitor cells and uses thereof |
| 01/23/1997 | WO1997002039A1 Antibacterial synergistic composition comprising rifabutin |
| 01/23/1997 | WO1997002036A1 4-(2-(n-2-carboxamidoindole)aminoethyl)-benzenesulfonamides or sulfonylureas as pdgf antagonists |
| 01/23/1997 | WO1997000063A3 Urocortin peptides |
| 01/23/1997 | WO1996040777A3 Synthetic peptides and pharmaceutical compositions comprising them |
| 01/23/1997 | WO1996040258A3 Spironolactone and angiotensin ii antagonist combination therapy for treatment of congestive heart failure |
| 01/23/1997 | WO1996040168A3 Use of hydroxyethyl starch to prevent post surgical adhesion and as an intracavity carrier device |
| 01/23/1997 | WO1996038558A3 A human purinergic p2u receptor |
| 01/23/1997 | WO1996028151A3 Use of a pyruvate dehydrogenase activator for the treatment of ischaemia in limbs |
| 01/23/1997 | CA2226417A1 Neuronal progenitor cells and uses thereof |
| 01/23/1997 | CA2225959A1 Cascade polymer complexes, process for their production and pharmaceutical agents containing said complexes |
| 01/23/1997 | CA2225616A1 Novel azepanes and their ring homologues for therapy and prophylaxis of protein kinase mediated diseases |
| 01/23/1997 | CA2222725A1 Therapeutic agents |